ICI MALATHION ULV CONCENTRATE INSECTICIDE

Main information

  • Trade name:
  • ICI MALATHION ULV CONCENTRATE INSECTICIDE
  • Class:
  • AgChem
  • Medicine domain:
  • Plants
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • ICI MALATHION ULV CONCENTRATE INSECTICIDE
    Australia
  • Language:
  • English

Therapeutic information

  • Therapeutic group:
  • CEREAL CROP | FIELD CROP | FIELD PEA | FOREST | LUCERNE PASTURE - REFER TO LABEL | MEDIC PASTURE | PASTURE | PEACH | SUDAN GRASS
  • Therapeutic area:
  • INSECTICIDE
  • Therapeutic indications:
  • AUSTRALIAN PLAGUE LOCUST | BLACK FIELD CRICKET | BLUEGREEN APHID | CRICKET | LOCUST | LUCERNE FLEA | MOSQUITO LARVA | ORIENTAL FRUIT MOTH | PEA WEEVIL | PHASMATID NYMPH | REDLEGGED EARTH MITE | RUTHERGLEN BUG | SMALL PLAGUE GRASSHOPPER | SORGHUM MIDGE | SPOTTED ALFALFA APHID | WINGLESS GRASSHOPPER | CLOVER SPRINGTAIL | FIELD CRICKET | OCHLEROTATUS VIGILAX | RED LEGGED EARTH MITE | THERIOAPHIS TRIFOLII

Other information

Status

  • Source:
  • Australian Pesticides and Veterinary Medicines Authority (APVMA)
  • Authorization status:
  • Archived
  • Authorization number:
  • 33016
  • Last update:
  • 09-08-2016

18-12-2018


Scientific recommendation on classification of advanced therapy medicinal products: Concentrate of autologous bone marrow-derived mononuclear cells (BM-MNC)

Scientific recommendation on classification of advanced therapy medicinal products: Concentrate of autologous bone marrow-derived mononuclear cells (BM-MNC)

Scientific recommendation on classification of advanced therapy medicinal products: Concentrate of autologous bone marrow-derived mononuclear cells (BM-MNC)

Europe - EMA - European Medicines Agency

12-12-2018


Scientific recommendation on classification of advanced therapy medicinal products: Autologous concentrated bone marrow

Scientific recommendation on classification of advanced therapy medicinal products: Autologous concentrated bone marrow

Scientific recommendation on classification of advanced therapy medicinal products: Autologous concentrated bone marrow

Europe - EMA - European Medicines Agency

2-10-2018

NexoBrid (MediWound Germany GmbH)

NexoBrid (MediWound Germany GmbH)

NexoBrid (Active substance: Concentrate of proteolytic enzymes enriched in bromelain) - PSUSA - Modification - Commission Decision (2018)6460 of Tue, 02 Oct 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/PSUSA/10028/201712

Europe -DG Health and Food Safety

29-8-2018

Fulvestrant Mylan (Mylan S.A.S.)

Fulvestrant Mylan (Mylan S.A.S.)

Fulvestrant Mylan (Active substance: fulvestrant) - Centralised - 2-Monthly update - Commission Decision (2018)5774 of Wed, 29 Aug 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/004649/IB/0001

Europe -DG Health and Food Safety